Cargando…
An MCASE approach to the search of a cure for Parkinson's Disease.
BACKGROUND: Parkinson's disease is caused by a dopamine deficiency state in the fore brain area. Dopamine receptor agonists, MAO-B inhibitors, and N-Methyl-D-Aspartate (NMDA) receptor antagonists are known to have antiparkinson effect. Levodopa, a dopamine structural analog, is the best current...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107836/ https://www.ncbi.nlm.nih.gov/pubmed/11926966 http://dx.doi.org/10.1186/1471-2210-2-8 |